Ungstöd Sverige AB has been acquired by Nytida AB
Nytida AB has acquired Ungstöd Sverige AB for US$10 million.
Ungstöd, founded in 2007 and headquartered in Stockholm, is a non-institutional care provider offering services requiring state permits in accordance with the Social Services Act (sv. SoL) and the Act Concerning Support and Service for Persons with Certain Functional Impairments (sv. LSS). Ungstöd is a specialized care provider offering support and care for children with social and psychiatric problems.
Nytida AB is a leading player in the Swedish market offering support and assistance to people with medical and social disabilities. The company, with 250 established operations throughout the country and sales of approximately US$117 million, offers a wide range of non-institutional care services.
“Avantus has supported us throughout the whole process, with great commitment and sector expertise, and has played a pivotal role in what has become an outcome far beyond our expectations”, said Emil Wallgren, co-founder and CEO, Ungstöd.
Oaklins' team in Sweden advised the seller in this transaction.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn moreSLT has been acquired by Indutrade
SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.
Learn more